What is ventricular bigeminy?
Emojis in electronic health records could be confusing
Doing different types of exercise linked to a longer life
CPR on TV may be misleading
How gum disease may raise heart disease risk
FDA approves nasal spray to treat rapid heart rhythm
Smart watch may improve detection of atrial fibrillation
Understanding food noise - and how to turn down the volume
4 keys to a heart-healthy diet
Understanding exercise heart rate zones
C.W. Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
C.W. Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, he has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by C.W. Schmidt
C.W. Schmidt
Can a man with abnormal PSA and a negative diagnostic MRI avoid a prostate biopsy? It’s debatable
C.W. Schmidt
Highly accurate test reveals recurring prostate cancer
C.W. Schmidt
African American men respond better to treatments for advanced prostate cancer in clinical trials
C.W. Schmidt
Diet and exercise limit heart disease risk in men undergoing hormonal treatments for advanced prostate cancer
C.W. Schmidt
Hormonal therapy for aggressive prostate cancer: How long is enough?
C.W. Schmidt
Long-term statin use protects against prostate cancer death
C.W. Schmidt
Smoking tied to more aggressive prostate cancer
C.W. Schmidt
Investigators unveil metastatic prostate cancer’s genomic landscape
C.W. Schmidt
A new option for immunotherapy in metastatic prostate cancer
C.W. Schmidt
Q&A with Dr. Daniel Rukstalis on prostatic urethral lift for enlarged prostates
C.W. Schmidt
New blood test may someday help guide the best treatment for aggressive prostate cancer
C.W. Schmidt
New blood test guides researchers toward the best treatment for aggressive prostate cancer
C.W. Schmidt
Influential task force issues new recommendations on prostate cancer screening
C.W. Schmidt
Diagnostic MRIs allow some men flagged by PSA screening to avoid a biospy, new study shows
C.W. Schmidt
New study once again casts doubt on PSA screening
Cancer
A mix of treatments may extend life for men with aggressive prostate cancer
C.W. Schmidt
A mix of treatments may extend life for men with aggressive prostate cancer
Cancer
FDA approves new drug for men at high risk of prostate cancer spread
C.W. Schmidt
FDA approves new drug for men at high risk of prostate cancer spread
Cancer
Newer drugs are improving survival for men with metastatic prostate cancer
C.W. Schmidt
New study downplays potential risk of dementia and Alzheimer’s disease among elderly men treated with hormonal therapy for prostate cancer
Cancer
Study investigates treatment regret among prostate cancer survivors
C.W. Schmidt
Study investigates treatment regret among prostate cancer survivors
C.W. Schmidt
New study supports lifesaving benefits from PSA screening
What is ventricular bigeminy?
Emojis in electronic health records could be confusing
Doing different types of exercise linked to a longer life
CPR on TV may be misleading
How gum disease may raise heart disease risk
FDA approves nasal spray to treat rapid heart rhythm
Smart watch may improve detection of atrial fibrillation
Understanding food noise - and how to turn down the volume
4 keys to a heart-healthy diet
Understanding exercise heart rate zones
